Nordisk

Money

Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs

Key Takeaways Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies’…

Read More »
Money

Novo Nordisk Stock Rises on Earnings Beat, Narrowed Outlook

Key Takeaways Novo Nordisk’s U.S.-listed shares rose Wednesday morning as third-quarter profits beat estimates and sales of Ozempic and Wegovy…

Read More »
Money

Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025

Key Takeaways Hims’ third-quarter results topped expectations, driven in part by revenue from its weight-loss drugs. The company said it…

Read More »
Money

Novo Nordisk Stock Slips as CEO Faces Senate Inquiry Into Wegovy, Ozempic Prices

Key Takeaways Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker’s…

Read More »
Money

Novo Nordisk Sinks on Obesity Drug Study’s Disappointing Results

Key Takeaways Novo Nordisk’s U.S.-listed shares lost ground Friday after a Phase 2a trial of the pharmaceutical firm’s latest obesity…

Read More »
Money

What You Need To Know Ahead of Novo Nordisk Earnings Wednesday

<img src='https://www.investopedia.com/thmb/AIq_avuLkl5zDDidl7t0N1Y3JP0=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1690265028-388edef8c47f4184bfba3e5deda32f0c.jpg' alt=' Christian Schultz / picture alliance / Getty Images ‘ title=”Novo Nordisk logo on office building”> Christian Schultz…

Read More »
Money

Novo Nordisk Gains as Ozempic Found To Lower Dementia Rates

Key Takeaways American depositary receipts (ADRs) of Novo Nordisk rose in intraday trading Friday after an Oxford study showed the…

Read More »
Money

Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices

Key Takeaways Novo Nordisk and Eli Lilly shares lost ground Tuesday after U.S. President Joe Biden and Senator Bernie Sanders…

Read More »
Money

Novo Nordisk Rises as Wegovy Is Approved in China

Key Takeaways American depositary receipts (ADRs) of Danish drugmaker Novo Nordisk rose Tuesday after the company announced that its popular…

Read More »
Back to top button